{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:43:56Z","timestamp":1762875836817},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.amjcard.2016.08.088","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T05:01:07Z","timestamp":1474347667000},"page":"1941-1947","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"118","author":[{"given":"Paul A.","family":"Gurbel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin P.","family":"Bliden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gailing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya S.","family":"Tantry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2016.08.088_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijcard.2014.05.013","article-title":"24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis","volume":"175","author":"W\u00fcrtz","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/09537104.2014.901497","article-title":"Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes","volume":"26","author":"Christensen","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.amjcard.2016.08.088_bib3","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1538-7836.2012.04723.x","article-title":"The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes","volume":"10","author":"Rocca","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.amjcard.2016.08.088_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/157016112800812818","article-title":"Antiplatelet therapy in patients with diabetes mellitus","volume":"10","author":"Grove","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2011.04304.x","article-title":"Increased platelet turnover in patients with previous definite stent thrombosis","volume":"9","author":"Grove","year":"2011","journal-title":"J\u00a0Thromb Haemos"},{"key":"10.1016\/j.amjcard.2016.08.088_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/fca.15.60","article-title":"Drug delivery and therapeutic impact of extended-release acetylsalicylic acid","volume":"12","author":"Bliden","year":"2016","journal-title":"Future Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib7","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2016.08.088_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.thromres.2008.03.023","article-title":"Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry","volume":"123","author":"Nielsen","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2016.08.088_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacc.2014.05.049","article-title":"Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry","volume":"64","author":"Mayer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib10","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib11","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","article-title":"Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation","volume":"46","author":"Tantry","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib12","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.thromres.2009.05.003","article-title":"Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone","volume":"126","author":"Antonino","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2016.08.088_bib13","doi-asserted-by":"crossref","first-page":"e9340","DOI":"10.1371\/journal.pone.0009340","article-title":"Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT","volume":"5","author":"Montine","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2016.08.088_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH08-03-0186","article-title":"Immature platelets in patients with acute coronary syndromes","volume":"101","author":"Grove","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2016.08.088_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.6061\/clinics\/2015(02)05","article-title":"Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism","volume":"70","author":"Bilgir","year":"2015","journal-title":"Clinics"},{"key":"10.1016\/j.amjcard.2016.08.088_bib16","article-title":"Evaluation of the EndoPAT as a tool to assess endothelial function","volume":"2012","author":"Moerland","year":"2012","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.amjcard.2016.08.088_bib17","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/ATVBAHA.115.306371","article-title":"Inhibited and uninhibited platelet deposition within a thrombus: does it depend on the antiplatelet drug?","volume":"35","author":"Gurbel","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12185-010-0652-3","article-title":"Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes","volume":"92","author":"Addad","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH11-04-0216","article-title":"Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications","volume":"106","author":"Spectre","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2016.08.088_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/CIRCINTERVENTIONS.111.961847","article-title":"Further ex\u00a0vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes","volume":"4","author":"Bliden","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2016.08.088_bib21","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00325481.2015.1050341","article-title":"A\u00a0randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation","volume":"127","author":"Patrick","year":"2015","journal-title":"Postgrad Med"},{"key":"10.1016\/j.amjcard.2016.08.088_bib22","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2337\/db07-0707","article-title":"The effect of aspirin dosing on platelet function in diabetic and non-diabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study","volume":"56","author":"DiChiara","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.amjcard.2016.08.088_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.prostaglandins.2015.07.004","article-title":"Aspirin and lipid mediators in the cardiovascular system","volume":"121","author":"Schr\u00f6r","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.amjcard.2016.08.088_bib24","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/S0021-9258(18)53294-4","article-title":"Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs","volume":"268","author":"Meade","year":"1993","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.amjcard.2016.08.088_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1124\/mol.51.1.52","article-title":"Altered sensitivity of aspirin-acetylated prostaglandin G\/H synthase-2 to inhibition by nonsteroidal anti-inflammatory drugs","volume":"51","author":"Mancini","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.amjcard.2016.08.088_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80579-2","article-title":"Mutation of serine-516 in human prostaglandin G\/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis","volume":"342","author":"Mancini","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.amjcard.2016.08.088_bib27","doi-asserted-by":"crossref","first-page":"13207","DOI":"10.1016\/S0021-9258(17)36820-5","article-title":"Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin","volume":"269","author":"Lecomte","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.amjcard.2016.08.088_bib28","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Cl\u00e0ria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916315041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914916315041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T03:40:35Z","timestamp":1724470835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914916315041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0002914916315041"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.088","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2016.08.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}